Evidence map›Paper›PMID 26485645›Full record

ArticlePLoS genetics2015

The Ciliopathy Protein CC2D2A Associates with NINL and Functions in RAB8-MICAL3-Regulated Vesicle Trafficking.

Ruxandra Bachmann-Gagescu, Margo Dona, Lisette Hetterschijt, Edith Tonnaer, Theo Peters, Erik de Vrieze, Dorus A Mans, Sylvia E C van Beersum, Ian G Phelps, Heleen H Arts and 9 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Integrative genomic and functional analyses reveal NINL as a modulator of tau aggregation.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Formylation facilitates the reduction of oxidized initiator methionines.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Nlp-dependent ER-to-Golgi transport.International journal of biological sciences · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 5 countries.

Ruxandra Bachmann-GagescuInstitute for Molecular Life Sciences, University of Zurich, Zurich, Switzerland; Institute of Medical Genetics, University of Zurich, Zurich, Switzerland.
Margo DonaDepartment of Otorhinolaryngology, Radboud University Medical Centre, Nijmegen, the Netherlands; Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, the Netherlands.
Lisette HetterschijtDepartment of Otorhinolaryngology, Radboud University Medical Centre, Nijmegen, the Netherlands; Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, the Netherlands.
Edith TonnaerDepartment of Otorhinolaryngology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Theo PetersDepartment of Otorhinolaryngology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Erik de VriezeDepartment of Otorhinolaryngology, Radboud University Medical Centre, Nijmegen, the Netherlands; Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, the Netherlands.
Dorus A MansRadboud Institute for Molecular Life Sciences, Radboud University Nijmegen, the Netherlands; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands.
Sylvia E C van BeersumRadboud Institute for Molecular Life Sciences, Radboud University Nijmegen, the Netherlands; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands.
Ian G PhelpsDepartment of Pediatrics, University of Washington, Seattle, Washington, United States of America.
Heleen H ArtsRadboud Institute for Molecular Life Sciences, Radboud University Nijmegen, the Netherlands; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Biochemistry, University of Western Ontario, London, Ontario, Canada.
Jan E KeunenDepartment of Ophthalmology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Marius UeffingDivision of Experimental Ophthalmology and Medical Proteome Center, Centre for Ophthalmology, Eberhard Karls University Tuebingen, Germany.
Ronald RoepmanRadboud Institute for Molecular Life Sciences, Radboud University Nijmegen, the Netherlands; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands.
Karsten BoldtDivision of Experimental Ophthalmology and Medical Proteome Center, Centre for Ophthalmology, Eberhard Karls University Tuebingen, Germany.
Dan DohertyDepartment of Pediatrics, University of Washington, Seattle, Washington, United States of America.
Cecilia B MoensFred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Stephan C F NeuhaussInstitute for Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Hannie KremerDepartment of Otorhinolaryngology, Radboud University Medical Centre, Nijmegen, the Netherlands; Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, the Netherlands; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands.
Erwin van WijkDepartment of Otorhinolaryngology, Radboud University Medical Centre, Nijmegen, the Netherlands; Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, the Netherlands.
Radboud University Medical Center · NLRadboud University Nijmegen · NLSTZ eyetrial · DEUniversity of Washington · USUniversity of Zurich · CHFred Hutch Cancer Center · USRadboud Institute for Molecular Life Sciences · NL

Funding

Restoring FMRP Phenotypes Frpm Temporal Regional and Splice- Isoforms VarationsP30HD002274 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 1985 to 2013
$33.6M
Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 2014 to 2019
$7.9M
Mechanisms of Tangential Neuron MigrationR01NS082567 · NINDS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MOENS, CECILIA B · 2013 to 2017
$2.1M
Joubert syndrome and related disorders of hindbrain developmentR01NS064077 · NINDS · UNIVERSITY OF WASHINGTON · PI DOHERTY, DANIEL · 2010 to 2014
$1.8M
NICHD NIH HHS P30 HD002274NICHD NIH HHS U54 HD083091NINDS NIH HHS R01 NS064077NINDS NIH HHS R01NS064077NINDS NIH HHS R01 NS082567
6 · The paper itself

Abstract

Ciliopathies are a group of human disorders caused by dysfunction of primary cilia, ubiquitous microtubule-based organelles involved in transduction of extra-cellular signals to the cell. This function requires the concentration of receptors and channels in the ciliary membrane, which is achieved by complex trafficking mechanisms, in part controlled by the small GTPase RAB8, and by sorting at the transition zone located at the entrance of the ciliary compartment. Mutations in the transition zone gene CC2D2A cause the related Joubert and Meckel syndromes, two typical ciliopathies characterized by central nervous system malformations, and result in loss of ciliary localization of multiple proteins in various models. The precise mechanisms by which CC2D2A and other transition zone proteins control protein entrance into the cilium and how they are linked to vesicular trafficking of incoming cargo remain largely unknown. In this work, we identify the centrosomal protein NINL as a physical interaction partner of CC2D2A. NINL partially co-localizes with CC2D2A at the base of cilia and ninl knockdown in zebrafish leads to photoreceptor outer segment loss, mislocalization of opsins and vesicle accumulation, similar to cc2d2a-/- phenotypes. Moreover, partial ninl knockdown in cc2d2a-/- embryos enhances the retinal phenotype of the mutants, indicating a genetic interaction in vivo, for which an illustration is found in patients from a Joubert Syndrome cohort. Similar to zebrafish cc2d2a mutants, ninl morphants display altered Rab8a localization. Further exploration of the NINL-associated interactome identifies MICAL3, a protein known to interact with Rab8 and to play an important role in vesicle docking and fusion. Together, these data support a model where CC2D2A associates with NINL to provide a docking point for cilia-directed cargo vesicles, suggesting a mechanism by which transition zone proteins can control the protein content of the ciliary compartment.

Indexed as

Abnormalities, MultipleAnimalsCerebellumCiliaCiliary Motility DisordersCytoskeletal ProteinsEncephaloceleEye AbnormalitiesGene Knockdown TechniquesHumansKidney Diseases, CysticMicrotubule-Associated ProteinsMixed Function OxygenasesMutationNuclear ProteinsPolycystic Kidney DiseasesCC2D2A protein, humanCytoskeletal ProteinsMICAL3 protein, humanMicrotubule-Associated ProteinsMixed Function OxygenasesNINL protein, humanNuclear ProteinsProteinsRAB8A protein, humanrab GTP-Binding Proteins

Identifiers

PMID26485645
PMCPMC4617701
OpenAlexW1771227799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.